Bullett drug delivery catheters cleared in US
This article was originally published in Clinica
Endosonics subsidiary Cardiovascular Dynamics (US) has received US FDA clearance to market three models of its Bullett F/X drug delivery catheters. The site-specific catheters use multiple microporous membrane technology to deliver to remote sites in the body, according to the company.
You may also be interested in...
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.
Momenta Pharmaceuticals has agreed to pay $35.0m to settle claims that it manipulated generic approval processes in the US to shut competitor Amphastar out of the US enoxaparin market.